Medicare Advantage updates while halting proposed anti-obesity drug coverage, impacting millions of potential beneficiaries.

Kennedy Jr. has criticized the class of weight loss drugs known as GLP-1s, arguing the obesity problem can be solved by ...

A proposal by the Biden administration to cover weight-loss medicines for obesity under Medicare has been axed by the White ...

Medicare covers health care expenses mainly ... would have extended coverage of drugs like tirzepatide (Zepbound) and semaglutide (Wegovy). The rule was not expected to be finalized until Trump ...

Additionally, after the FDA approved Wegovy (Semaglutide) for treating heart disease, including for those with obesity or overweight, Medicare plans may be able to cover it for those who require ...

Compounded semaglutide and Ozempic are different products. While both may be used in people with type 2 diabetes, Ozempic is approved by the FDA, but compounded semaglutide is not. Compounded ...

Medicare Part D prescription drug plans and ... liraglutide (Victoza) semaglutide (Ozempic) exenatide (Bydureon) Other medications that are not glucagon-like peptide-1 receptor agonists are ...

An analysis of differential coding patterns between Medicare Advantage (MA) and Traditional Medicare (TM) plans estimated how much coding differs between insurers and how much extra revenue insurers ...

Emergency room visits attributed to popular weight loss drugs such as Ozempic and Wegovy remain quite rare overall, but do ...